Monoclonal antibodies are engineered proteins designed to bind to specific targets found on cancer cells. By targeting these unique markers, monoclonal antibodies can block the growth of cancer cells, trigger the immune system to destroy them, or deliver cytotoxic agents directly to the tumor.
